Test Price
2,800 AED✅ Home Collection Available
APP Gene Cerebral Amyloid Angiopathy (CAA) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين APP للاعتلال الوعائي النشواني الدماغي في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary & Clinical Assurance
يقدم فحص الجينات المتقدم هذا تشخيصًا دقيقًا للاعتلال الوعائي النشواني الدماغي المرتبط بجين APP، مع ضمان دقة 99.9% وخدمة جمع منزلية وفق معايير الجودة العالمية.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation with a DHA-licensed neurologist.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Comparison
This Next‑Generation Sequencing (NGS) assay analyses the entire APP gene to detect pathogenic variants linked to hereditary cerebral amyloid angiopathy (CAA) and familial Alzheimer’s disease.
يستخدم هذا الاختبار تقنية التسلسل الجيني المتقدم لتحليل كامل جين APP المرتبط بالاعتلال الوعائي النشواني الدماغي الوراثي.
| Feature | Our Test (NGS – CAA Panel) | Closest Alternative (Single‑Gene Sanger Sequencing) |
|---|---|---|
| Precision | 99.9% diagnostic sensitivity for all coding exons ±20 bp of intron/exon boundaries | ~98% sensitivity; may miss large deletions or copy‑number variants |
| Methodology | Next‑Generation Sequencing (NGS) with Illumina® platform, verified by Sanger confirmation | Capillary Electrophoresis Sanger Sequencing |
| Turnaround Time | 3–4 Weeks (ISO‑certified cold‑chain handling) | 6–8 Weeks (often outsourced) |
| Regulatory Compliance | DHA/MOHAP Standard Nomenclature, UAE PDPL, Federal Decree‑Law No. 41/2024 Art. 87, CDS Law 2026 (Minors) | Variable; may lack local legal safeguards |
Physician Insight & Safety Protocol
“As a DHA‑certified neurologist, I emphasise that an APP gene variant is not a diagnosis in isolation; it must be correlated with clinical symptoms, neuroimaging, and family history. This test provides critical risk information, and I urge you to discuss results with a genetics‑trained specialist before making any health decisions.”
— Dr. PRABHAKAR REDDY, DHA Licence: 61713011
⚠️ Medication Warning: Do not discontinue prescribed medication without consulting your doctor. Genetic results do not replace ongoing clinical care.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Patients unable to provide informed consent (legal guardian required); active severe neurological deterioration requiring immediate hospitalisation.
- Emergency Red Flags (seek immediate medical attention): Sudden severe headache, acute confusion, new‑onset seizures, or stroke‑like symptoms after receiving results.
- Genetic Counselling Mandate: Pre‑test genetic counselling and a three‑generation pedigree are required under UAE Federal Decree‑Law No. 41 of 2024, Art. 87. Minors (< 18 years) must have parental consent and comply with CDS Law 2026.
Patient FAQ & Clinical Guidance
1. What exactly does the APP gene NGS test detect?
This NGS test comprehensively screens the entire APP gene for single‑nucleotide variants, small insertions/deletions, and copy‑number changes linked to hereditary cerebral amyloid angiopathy and early‑onset Alzheimer’s disease, using Illumina‑based sequencing with >99.9% analytical sensitivity.
يكتشف فحص التسلسل الجيني الكامل طفرات جين APP المسؤولة عن الاعتلال الوعائي النشواني الدماغي الوراثي ومرض الزهايمر المبكر.
2. How should I prepare for the test, and is it painful?
A simple blood draw or one drop of blood on an FTA card is sufficient; the procedure is minimally invasive and performed by a DHA‑licensed phlebotomist during a home visit. No fasting is required, but you must complete a pre‑test genetic counselling session and provide a detailed family history.
يتطلب الاختبار عينة دم بسيطة أو قطرة دم على بطاقة FTA، ويتم جمعها بواسطة أخصائي مرخص من هيئة الصحة بدبي مع جلسة استشارة وراثية مسبقة.
3. What happens after I receive my results?
Your report will be interpreted by a multidisciplinary team including a neurologist and a clinical geneticist, followed by a telephonic consultation to explain the findings, assess risk for family members, and coordinate a personalised management plan. You will never be left without expert support.
يتم تفسير النتائج من قبل فريق طبي متخصص يشمل طبيب أعصاب وأخصائي جينات، مع استشارة هاتفية لشرح النتائج وخطة المتابعة.
Legal Disclaimers: This complies with UAE Federal Decree‑Law No. 41 of 2024 (Art. 87 – Genetic Testing Consent & Privacy), CDS Law 2026 regarding minors’ genetic data, and the UAE Personal Data Protection Law (PDPL). Genetic results must be interpreted in conjunction with clinical assessment. Testing is performed by DHA‑licensed facility (No. 9834453).
Accreditation: ISO 9001:2015 Quality Management System – Certificate: INT/EGQ/2509DA/3139.
Contact & Support: WhatsApp +971 54 548 8731 for insurance verification, home collection scheduling (8 AM – 11 PM), or genetic counselling appointments.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians